Back to search

Article

WITHDRAWN: GATA2 promotes castration-resistant prostate cancer development by suppressing IFN-β axis-mediated antitumor immunity

2024-02-23

Abstract excerpt

<title>Abstract</title> <p> Castration-resistant prostate cancer (CRPC) nearly inevitably develops after long-term treatment with androgen deprivation therapy (ADT), leading to significant mortality. Investigating the mechanisms driving CRPC development is imperative. Here, we determined that the pioneer transcription factor <italic>GATA2</italic> , which is frequently amplified in CRPC patients, inhibits inte...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
86f6cd3d-8389-5c76-bf38-479ddbfb04cc
DOI
10.21203/rs.3.rs-3958845/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
WITHDRAWN: GATA2 promotes castration-resistant prostate cancer development by suppressing IFN-β axis-mediated antitumor immunityDOI 10.21203/rs.3.rs-3958845/v1
Select a neighboring publication to make it the new centre.